Accessibility Menu
Sysmex logo

Sysmex(OTC) SSMXY

Market Cap$7.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)+109%
5 Year-65%
1 Year-12%
1 Month+23%
$12.02
+1.50%
+0.18Today
Sysmex last closing stock price
MetricPriceDate
Last closeUSD 11.842026-08-13
Sysmex stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+14.95%USD 10.302026-08-06
1 month+23.2%USD 9.612026-07-14
3 month+41.29%USD 8.382026-05-15
Year to date+23.15%USD 9.612025-12-31
1 year-12.26%USD 13.492025-08-13
3 year-31.63%USD 17.322023-08-14
5 year-65.29%USD 34.112021-08-13
Since inception+108.94%USD 5.672011-10-17

Sysmex Financials at a Glance

Market Cap

$7.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥533.75B

Net Income (TTM)

¥40.23B

EPS (TTM)

$0.42

P/E Ratio

28.37

Dividend

$0.24

Beta (Volatility)

0.72 (Low)

Price

$12.02

Volume

4,989

Open

$12.11

Previous Close

$11.84

Daily Range

$11.85 - $12.14

52-Week Range

$8.01 - $13.57

Estimated Earnings Date

Aug 5, 2026

SSMXY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sysmex

Sysmex Corporation, headquartered in Kobe, Japan, is a leading developer, manufacturer, and distributor of diagnostic instruments, reagents, and specialized software. The company serves a wide range of medical needs, focusing on hematology, urinalysis, immunochemistry, and oncology diagnostics.

Products and Services
  • Diagnostic instruments for hematology and urinalysis
  • Automated systems for immunochemistry assays
  • Flow cytometers for critical condition diagnostics
Growth Outlook
  • Strategic alliance with QIAGEN for cancer diagnostics development
  • Expansion into digital medicine with IT solutions for diagnostics
  • Global reach, exporting products to approximately 190 countries
Financial Highlights
  • Recent quarterly revenue of 141.39 billion JPY, showing strong demand
  • Net income of 1.76 billion JPY in the latest quarter, reflecting profitability
  • TTM gross profit margin of 51.14%, indicating operational efficiency
Sysmex Corporation has established itself as a key player in the medical instruments and supplies industry. The company's diverse product offerings cater to various diagnostic needs, making it a vital partner for healthcare institutions worldwide. The strategic alliance with QIAGEN N.V. enhances Sysmex's capabilities in cancer diagnostics, positioning the company for future growth. With a strong focus on digital medicine, Sysmex is adapting to the evolving healthcare landscape, ensuring its relevance in the market. Recent financial performance highlights a robust revenue stream and profitability, underscoring the company's operational efficiency and market demand. Overall, Sysmex Corporation presents a compelling opportunity for investors interested in the healthcare sector.
AI Generated • Jul 23, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

10,861

CEO

Hisashi Ietsugu

Website

www.sysmex.co.jp/corporate/info/group.html

Headquarters

Kobe, HY 651-0073, JP

SSMXY Financials

Key Financial Metrics (TTM)

Gross Margin

50.96%

Operating Margin

13.12%

Net Income Margin

7.54%

Return on Equity

8.02%

Return on Capital

11.40%

Return on Assets

5.30%

Earnings Yield

3.52%

Dividend Yield

2.02%

Payout Ratio

59.72%

Stock Overview

Market Cap

$7.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

605.21M

Volume

4.99K

Avg. Volume

129.98K

Financials (TTM)

Gross Profit

¥272.01B

Operating Income

¥70.05B

EBITDA

¥120.25B

Operating Cash Flow

¥101.45B

Capital Expenditure

-¥34.08B

Free Cash Flow

¥67.37B

Cash & ST Invst.

¥112.88B

Total Debt

¥122.71B

Sysmex Performance Analysis

Sysmex annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31JPY 3,030,365,730-6.4%
20242024-03-31JPY 3,195,755,5625.5%
20252025-03-31JPY 3,336,449,8284.4%
20262026-03-31JPY 3,318,064,119-0.6%
Sysmex sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-3022.0%
Q32025-12-311.5%
Q42026-03-318.0%
Q12026-06-30-6.4%
Sysmex annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31JPY 0.54-13.8%
20242024-03-31JPY 0.552.0%
20252025-03-31JPY 0.562.9%
20262026-03-31JPY 0.38-33.1%
Sysmex sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30228.8%
Q32025-12-31-2.0%
Q42026-03-31-87.7%
Q12026-06-30396.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

¥132.39B

+25.2%

Gross Profit

¥67.18B

+23.4%

Gross Margin

50.74%

N/A

Market Cap

$7.17BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$659.76K

N/A

Employees

10,861

N/A

Net Income

¥8.81B

+93.4%

EBITDA

¥28.89B

+35.0%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

¥112.88B

+51.6%

Total Debt

¥122.71B

+90.3%

Accounts Receivable

¥163.68B

+14.2%

Inventory

¥106.13B

+20.7%

Long Term Debt

¥112.60B

+104.8%

Short Term Debt

¥10.11B

+6.5%

Return on Assets

5.30%

N/A

Return on Invested Capital

11.04%

N/A

Free Cash Flow

¥29.67B

+680.5%

Operating Cash Flow

¥36.06B

+279.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SKHCFSonic Healthcare Limited
$14.25+0.00%
KYKOFKyowa Kirin Co., Ltd.
$14.43+0.00%
SKHHYSonic Healthcare Limited
$15.92+0.87%
CNVVYConvaTec Group Plc
$12.58+0.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.06+0.08%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.69+0.01%
ONDSOndas
$9.14+0.03%
SPCXSpace Exploration Technologies
$139.49-0.01%

Questions About SSMXY

What is the current price of Sysmex?

Sysmex is trading at $12.02 per share.

What is the 52-week range for Sysmex?

Over the past 52 weeks, Sysmex has traded between $8.01 and $13.57.

How much debt does Sysmex have?

As of the most recent reporting period, Sysmex reported total debt of ¥760.04M.

How much cash does Sysmex have on hand?

Sysmex reported ¥699.18M in cash and cash equivalents in its most recent financial results.

What is Sysmex’s dividend yield?

Sysmex currently has a dividend yield of 2.02%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services